PSA levels: What It Says About The Prostate


PSA levels

The PSA levels were discovered in the US just over 40 years ago as a measure of the activity of prostate tissue (3Opens in a new tab.). The Prostate-Specific Antigen (PSA) is a protein produced exclusively by prostate cells (6Opens in a new tab.). It can be measured in the blood (PSA test) (2Opens in a new tab.). The PSA level is determined to assess the course of prostate cancer (1Opens in a new tab.). Whether it is also suitable for the early detection of cancerOpens in a new tab. is controversially discussed (5Opens in a new tab.). In the US, the statutory health insurance companies do not currently pay for the PSA test for early detectionOpens in a new tab. (PSA screening), but there are different cases (4Opens in a new tab.). In the European Union, these PSA levels tests are covered and free in general (9Opens in a new tab.). Find out all you need to know about the PSA levels here.

ICD code for this condition is C61

psa levels

What are the PSA levels?

PSA is an abbreviation for “prostate-specific antigen” (7Opens in a new tab.). It is a protein that is only produced by the prostate. It makes the seminal fluid more fluid.

The PSA test measures how much PSA circulates in the blood. Experts have established an age-dependent PSA standard value, but this is only a guide. It is impossible to give a generally valid limit value for PSA levels in healthy men. In general, however, the following applies: In the case of prostate cancer (prostate carcinoma), PSA levels are often significantly higher than the reference values mentioned here and continue to increase with tumor growth.

 

Age PSA standard range
up to 40 years < 1,4 µg/l
up to 50 years < 2,0 µg/l
up to 60 years < 3,1 µg/l
up to 70 years < 4,1 µg/l
for over 70 years < 4,4 µg/l

 

Caution: An elevated PSA level does not necessarily mean that the patient concerned has prostate cancer. Conversely, even with a normal PSA level, prostate cancer cannot be ruled out with certainty.

An elevated PSA level can also be caused, for example, by a benign enlargement of the prostate (BPH, benign prostatic hyperplasia), inflammation of the urinary tract or prostate, or a prostate infarction. In addition, PSA levels usually increase with age.

On the other hand, even a low (normal) PSA level is not a reliable proof that prostate cancer is not present. Measuring the PSA level alone is therefore not suitable for diagnosing or ruling out prostate cancer beyond doubt.

PSA Level For Early Detection Of Prostate Cancer

It has not yet been clarified how important the PSA levels actually is in the early detection of prostate cancerOpens in a new tab.. Since the introduction of PSA measurement, prostate cancer has been detected much more frequently and also earlier. However, only a few of the men who are diagnosed with prostate cancer would actually suffer or even die from it. This is because in many cases the prostate carcinoma grows very slowly and would therefore only lead to symptoms after years or even decades (clinically silent/latent prostate carcinoma).

However, the diagnosis of prostate cancer is very frightening for most of those affected and is therefore emotionally very stressful. In addition, many men undergo treatment after the diagnosisOpens in a new tab., which is often associated with side effects such as urinary incontinence or impotence. If one considers that only a minority of men would actually have experienced symptoms of prostate cancer, it becomes clear that many men are unnecessarily confronted with the stressful diagnosis of prostate cancer, and treatment would often be unnecessary.

Conclusion: So far, it is very controversial among experts whether the PSA levels are more harmful or beneficial for the early detection of prostate cancer.

PSA Levels Measurement And Follow-up Examinations

However, it is undisputed that measuring the PSA level after prostate cancer treatment is useful. For example, during surgery, the entire prostate gland is removed along with the surrounding tissue. Within a few weeks, the PSA level in the blood then falls into an undetectable range (below 0.2 nanograms per milliliter of blood).

If PSA in the blood is suddenly measured again in a follow-up examination, this can indicate a return of cancer (recurrence): Cancer cells could spread again in the area of the surgical site or elsewhere in the body. A PSA test can, therefore, be used to detect and treat a relapse at an early stage.

Early detection of prostate cancer: Conclusion

An important part of the early detection of prostate cancerOpens in a new tab. is a palpation examination via the anus: With one finger, the doctor palpates the prostate via the rectum for noticeable changes. This digital-rectal examination is paid for once a year by the statutory health insurance companies for all men over 45 years of age. However, it alone can only detect prostate cancer in an advanced stage.

In order to detect the malignant tumor earlier, men are therefore often offered further examinations (at their own expense): an ultrasound examination of the rectum (rectal ultrasound) as well as the PSA test. As mentioned above, the significance of PSA levels in the early detection of prostate cancerOpens in a new tab. is controversial. There is no recommendation that is valid for all men.

Health agencies advise all men to consult a doctor about the various examinations. In individual cases, men and doctors should then decide together whether the PSA level should also be determined as part of the early detection of prostate cancerOpens in a new tab..

 Scientific standards:

This text complies with the requirements of medical literature, medical guidelines and current studies and has been reviewed by medical experts.

 ICD codes:

    ICD codes are internationally valid codes for medical diagnoses. They can be found, for example, in doctors’ letters or on certificates of incapacity to work.

     

     

    Sandra Eades

    Hello I am Sandra Eades, physician, researcher and author from Australia. I am working currently as researcher for a private institution. I have studied in Britain and Australia, where I currently reside. I write about research topics in the organization of the public health government agencies. For the iMS I write about general medical conditions. I also research scholar sources to provide information to writers of other articles. I also check the citations of scholar papers. Finally, I read other articles before they are published. I am also a mother of three children!

    Recent Content